Meeting
2012 ASCO Annual Meeting
Proton radiotherapy for rhabomyosarcoma: Preliminary results from a multicenter prospective study.
Authors
Torunn I. Yock
Massachusetts General Hospital, Boston, MA
Torunn I. Yock , Jackie Szymonifka , Alison M. Friedmann , Anita Mahajan , Beow Yong Yeap , Shannon M. MacDonald , Hallie Bieber Kasper , David Grosshans , Karen Chayt Marcus , Nancy Tarbell
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Pediatric Solid Tumors
Clinical Trial Registration Number
NCT00592592
Citation
J Clin Oncol 30, 2012 (suppl; abstr 9585)
DOI
10.1200/jco.2012.30.15_suppl.9585
Abstract #
9585
Poster Bd #
44G
Abstract Disclosures
Similar Posters
Poster
2011 ASCO Annual Meeting
Clinical outcomes in adult and childhood rhabdomyosarcoma (RMS) treated with vincristine, dactinomycin, and cyclophosphamide (VAC)/VAC-like chemotherapy.
First Author: K. Harano
Poster
2017 ASCO Annual Meeting
Rhabdomyosarcoma (RMS) in adults: Histologic subtypes and overall survival with actinomycin-based chemotherapy vs doxorubicin-based chemotherapy.
First Author: Alia Vang
Poster
2022 ASCO Annual Meeting
Risk-adapted local therapy and intensive chemotherapy in patients with high-risk rhabdomyosarcoma.
First Author: Michael W. Bishop
Poster
2022 ASCO Annual Meeting
Dose intensity and outcomes of VDC/IE chemotherapy for adolescent and adult patients with Ewing’s family sarcoma.
First Author: Danielle Klingberg